{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:35:04Z","timestamp":1792636504394,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.intimp.2023.110281","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T06:35:33Z","timestamp":1683354933000},"page":"110281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Epicutaneous immunization with TNP-Ig antigen induces CD11c+IL-10+ dendritic cells that promote suppression of Th1-mediated contact hypersensitivity in humanized HLA-DR4 transgenic mice"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8295-3988","authenticated-orcid":false,"given":"Monika","family":"Majewska-Szczepanik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Strz\u0119pa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2072-7632","authenticated-orcid":false,"given":"Katarzyna","family":"Marci\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Szczepanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110281_b0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/ACI.0000000000000142","article-title":"Immunological mechanisms in allergic contact dermatitis","volume":"15","author":"Martin","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2023.110281_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2007.02381.x","article-title":"Contact dermatitis: epidemiology and frequent sensitizers to cosmetics","volume":"21","author":"Diepgen","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2023.110281_b0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.it.2004.06.003","article-title":"Extravascular T-cell recruitment requires initiation begun by Valpha14+ NKT cells and B-1 B cells","volume":"25","author":"Askenase","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nri3150","article-title":"Early immune events in the induction of allergic contact dermatitis","volume":"12","author":"Kaplan","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","article-title":"Critical role for NALP3\/CIAS1\/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1","volume":"24","author":"Sutterwala","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110281_b0030","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1398-9995.2011.02652.x","article-title":"Mechanisms of chemical-induced innate immunity in allergic contact dermatitis","volume":"66","author":"Martin","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2023.110281_b0035","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1084\/jem.184.6.2129","article-title":"Gamma delta T cells from tolerized alpha beta T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their interferon-gamma production in vitro","volume":"184","author":"Szczepanik","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110281_b0040","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/eji.1830251103","article-title":"Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene","volume":"25","author":"Bour","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0045","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.4049\/jimmunol.168.6.3079","article-title":"Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis","volume":"168","author":"Akiba","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1365-2133.2009.09400.x","article-title":"Th17\/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis","volume":"161","author":"Zhao","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2023.110281_b0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1600-0536.2012.02148.x","article-title":"Immunoregulation of skin sensitization and regulatory T cells","volume":"67","author":"Kimber","year":"2012","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.intimp.2023.110281_b0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2567.2005.02127.x","article-title":"Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta","volume":"115","author":"Szczepanik","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2023.110281_b0065","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/icb.2012.1","article-title":"Epicutaneous immunization with DNP-BSA induces CD4+ CD25+ Treg cells that inhibit Tc1-mediated CS","volume":"90","author":"Majewska-Szczepanik","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.110281_b0070","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (amino acids 83\u201399) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand","volume":"6","author":"Bielekova","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110281_b0075","doi-asserted-by":"crossref","unstructured":"L. Kappos, G. Comi, H. Panitch, J. Oger, J. Antel, P. Conlon, and L. Steinman, Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat Med 6 (2000) 1176-82.","DOI":"10.1038\/80525"},{"key":"10.1016\/j.intimp.2023.110281_b0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/CVI.00361-09","article-title":"Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice","volume":"17","author":"Yu","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0085","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1084\/jem.183.6.2635","article-title":"HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis","volume":"183","author":"Ito","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110281_b0090","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1002\/art.30639","article-title":"Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian alpha-enolase and arthritis in DR4-IE-transgenic mice","volume":"63","author":"Kinloch","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2023.110281_b0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2019.03.021","article-title":"The skin as an immune organ: Tolerance versus effector responses and applications to food allergy and hypersensitivity reactions","volume":"144","author":"Guttman-Yassky","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0100","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.pharep.2016.04.004","article-title":"Transdermal immunotherapy: Past, present and future","volume":"68","author":"Szczepanik","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2023.110281_b0105","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.4049\/jimmunol.156.11.4079","article-title":"Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice","volume":"156","author":"Wang","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI8624","article-title":"Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4","volume":"105","author":"Herrick","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110281_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/cyto.2002.1960","article-title":"Local but not systemic administration of IFN-gamma during the sensitization phase of protein antigen immunization suppress Th2 development in a murine model of atopic dermatitis","volume":"19","author":"Wang","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2023.110281_b0120","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1734-1140(12)70947-7","article-title":"Epicutaneous immunization with protein antigen TNP-Ig alleviates TNBS-induced colitis in mice","volume":"64","author":"Majewska-Szczepanik","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2023.110281_b0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneuroim.2005.04.007","article-title":"Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis","volume":"164","author":"Szczepanik","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2023.110281_b0130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaut.2007.02.017","article-title":"Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE)","volume":"28","author":"Tutaj","year":"2007","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2023.110281_b0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000375404","article-title":"Epicutaneous Immunization with Collagen Induces TCRalphabeta Suppressor T Cells That Inhibit Collagen-Induced Arthritis","volume":"166","author":"Marcinska","year":"2015","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pharep.2015.11.004","article-title":"Epicutaneous (EC) immunization with type II collagen (COLL II) induces CD4(+) CD8(+) T suppressor cells that protect from collagen-induced arthritis (CIA)","volume":"68","author":"Marcinska","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.intimp.2023.110281_b0145","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0150","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.4049\/jimmunol.154.8.3644","article-title":"Gamma delta T cells in normal spleen assist immunized alpha beta T cells in the adoptive cell transfer of contact sensitivity. Effect of Bordetella pertussis, cyclophosphamide, and antibodies to determinants on suppressor cells","volume":"154","author":"Askenase","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0008-8749(92)90228-H","article-title":"Regulation of contact sensitivity reaction: contrasuppressor T cells and contrasuppressor factor downregulate efferent T suppressor cells","volume":"144","author":"Ptak","year":"1992","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/imm.12466","article-title":"Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8(+) cell-derived exosomes","volume":"146","author":"Nazimek","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2023.110281_b0165","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ana.22219","article-title":"Immune regulation of multiple sclerosis by transdermally applied myelin peptides","volume":"68","author":"Jurynczyk","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2023.110281_b0170","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2013.3022","article-title":"Transdermal application of myelin peptides in multiple sclerosis treatment","volume":"70","author":"Walczak","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.intimp.2023.110281_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105966","article-title":"Oral treatment with enrofloxacin creates anti-inflammatory environment that supports induction of tolerogenic dendritic cells","volume":"77","author":"Strzepa","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.110281_b0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fimmu.2018.00455","article-title":"Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses","volume":"9","author":"Schulke","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaci.2016.11.052","article-title":"Broad spectrum antibiotic enrofloxacin modulates contact sensitivity through gut microbiota in a murine model","volume":"140","author":"Strzepa","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110281_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jgm.1436","article-title":"Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation induced by transduction-associated physical stress","volume":"12","author":"Besche","year":"2010","journal-title":"J. Gene Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923006033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923006033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:18:02Z","timestamp":1785770282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923006033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"alternative-id":["S1567576923006033"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110281","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epicutaneous immunization with TNP-Ig antigen induces CD11c+IL-10+ dendritic cells that promote suppression of Th1-mediated contact hypersensitivity in humanized HLA-DR4 transgenic mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110281"}}